SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
0.660
+0.020 (3.17%)
At close: Jun 26, 2026, 4:00 PM EDT
0.590
-0.070 (-10.56%)
After-hours: Jun 26, 2026, 7:03 PM EDT

Company Description

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America.

The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.

It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health.

In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters.

The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026.

The company was founded in 1997 and is headquartered in Long Beach, California.

SkinHealth Systems Inc.
SkinHealth Systems logo
Country United States
Founded 1997
Industry Household & Personal Products
Sector Consumer Staples
Employees 613
CEO Pedro Malha

Contact Details

Address:
3600 E. Burnett Street
Long Beach, California 90815
United States
Phone 800 603 4996
Website skinhealthsystems.com

Stock Details

Ticker Symbol SKIN
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001818093
CUSIP Number 88331L108
ISIN Number US88331L1089
Employer ID 85-1908962
SIC Code 3841

Key Executives

Name Position
Pedro Malha Chief Executive Officer, President and Director
Michael P. Monahan Chief Financial Officer
Sheri Lewis Chief Operations, Quality and Technology Officer
Paul Bokota J.D. Senior Vice President and General Counsel
Whitney Cypes Chief Brand and Clinical Innovation Officer

Latest SEC Filings

Date Type Title
Jun 22, 2026 8-K Current Report
Jun 16, 2026 8-K Current Report
May 21, 2026 8-K/A [Amend] Current report
May 20, 2026 144 Filing
May 12, 2026 8-K Current Report
May 11, 2026 SCHEDULE 13D/A Filing
May 7, 2026 10-Q Quarterly Report
May 7, 2026 8-K Current Report
May 6, 2026 8-K Current Report
May 6, 2026 SCHEDULE 13G/A Filing